Clinical Trial Update: A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

A multicenter phase 3 randomized trial evaluating bioequivalence of monometasone furoate nasal spray in seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Monometasone furoate nasal spray (monometasone furoate)

Snippet

Sponsor: Zheng Liu ENT | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: UNKNOWN